GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Yew Bio-Pharm Group Inc (OTCPK:YEWB) » Definitions » EPS without NRI

Yew Bio-Pharm Group (Yew Bio-Pharm Group) EPS without NRI : $-0.02 (TTM As of Sep. 2021)


View and export this data going back to 2013. Start your Free Trial

What is Yew Bio-Pharm Group EPS without NRI?

Yew Bio-Pharm Group's earnings per share without non-recurring items for the three months ended in Sep. 2021 was $-0.02. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2021 was $-0.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Yew Bio-Pharm Group's EPS without NRI or its related term are showing as below:

YEWB's 3-Year EPS without NRI Growth Rate is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 6.5
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Yew Bio-Pharm Group's EPS (Diluted) for the three months ended in Sep. 2021 was $-0.03. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2021 was $0.01.

Yew Bio-Pharm Group's EPS (Basic) for the three months ended in Sep. 2021 was $-0.03. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2021 was $0.01.


Yew Bio-Pharm Group EPS without NRI Historical Data

The historical data trend for Yew Bio-Pharm Group's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yew Bio-Pharm Group EPS without NRI Chart

Yew Bio-Pharm Group Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.06 0.09 -0.02 0.04

Yew Bio-Pharm Group Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 -0.01 0.02 -0.01 -0.02

Competitive Comparison of Yew Bio-Pharm Group's EPS without NRI

For the Farm Products subindustry, Yew Bio-Pharm Group's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yew Bio-Pharm Group's PE Ratio without NRI Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Yew Bio-Pharm Group's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Yew Bio-Pharm Group's PE Ratio without NRI falls into.



Yew Bio-Pharm Group EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yew Bio-Pharm Group  (OTCPK:YEWB) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Yew Bio-Pharm Group EPS without NRI Related Terms

Thank you for viewing the detailed overview of Yew Bio-Pharm Group's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Yew Bio-Pharm Group (Yew Bio-Pharm Group) Business Description

Traded in Other Exchanges
N/A
Address
9460 Telstar Avenue, Suite 6, El Monte, CA, USA, 91731
Yew Bio-Pharm Group Inc is a grower and seller of yew trees and manufacturer of products made from yew trees in China. The company also sells raw material, including the branches and leaves of yew trees, used in the manufacturing of traditional Chinese medicines, which are used as a secondary treatment for certain cancers, meaning they must be administered in combination with other pharmaceutical drugs. The company operating business segments are China and the United States, of which the majority of its revenue comes from China.
Executives
Yongchun Shi director 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91302
Xiefeng Liu director 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Guoshuang Tian director 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Xuehai Wu director 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Xingming Han director DOOR 3, FLOOR 7, VIC NO.23 TONGZHAN ST. XIANGFANG DISTRICT HARBIN CITY F4 XXXXXXXXX
Adam C Wasserman officer: Chief Financial Officer 1643 ROYAL GROVE WAY, WESTON FL 33327
Guifang Qi director, officer: Treasurer 501 N. MOORE AVE. APT. A MONTEREY PARK CA 91754
Zhiguo Wang director, officer: President and Secretary NO. 234, GEXIN STREET NANGANG DISTRICT HARBIN CITY F4 XXXXXXXXX

Yew Bio-Pharm Group (Yew Bio-Pharm Group) Headlines

From GuruFocus

Yew Bio-Pharm Group Announces New Significant Agreement

By Marketwired Marketwired 09-12-2018

Yew Bio-Pharm Group Announces New Cosmetic Subsidiary

By Marketwired Marketwired 03-09-2021